Company Profile · Healthcare

Shenzhen New Industries Biomedical

300832 · Shenzhen
Country
China
Employees
2,785
Buffett Score
93/100
Elite
Market capCN¥39.58B
Revenue (TTM)CN¥4.81B
EBITDACN¥2.14B
Profit margin35.68%
ROE19.87%
P/E (TTM)23
Forward P/E0
EPSCN¥2.19
Dividend yield2.42%
52-week rangeCN¥37.50 – CN¥65.49

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay analyzers, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.

No reports on this stock in your language yet.